(Q40609477)

22 September 2017

title

Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines (English)

1 reference

22 September 2017

1 reference

Matalliotakis IM

1

1 reference

22 September 2017

Goumenou AG

2

1 reference

22 September 2017

Koumantakis GE

3

1 reference

22 September 2017

Neonaki MA

4

1 reference

22 September 2017

Koumantakis EE

5

1 reference

22 September 2017

Dionyssopoulou E

6

1 reference

22 September 2017

Athanassakis I

7

1 reference

22 September 2017

Vassiliadis S

8

1 reference

22 September 2017

publication date

1 January 2003

1 reference

International Immunopharmacology

22 September 2017

published in

1 reference

22 September 2017

volume

3

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

81-89

1 reference

Monocyte chemotactic protein-1 expression in human preovulatory follicles and ovarian cells

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Immunology and endometriosis. Fact, artifact, or epiphenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Regulation of monocyte chemotactic protein-1 gene expression in human endometrial cells in cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Pathogenesis of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Vascular endothelial growth factor (VEGF) in endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Expression, production, and secretion of vascular endothelial growth factor and interleukin-6 by granulosa cells is comparable in women with and without endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Follicular hormonal environment and embryo quality in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

A randomized comparison of danazol and leuprolide acetate suppression of serum-soluble CD23 levels in endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

PRL, TSH and their response to the TRH test in patients with endometriosis before, during, and after treatment with danazol

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

The role of angiogenesis in the accumulation of peritoneal fluid in benign conditions and the development of malignant ascites in the female

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Vascular endothelial growth factor and the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Angiogenic activity of peritoneal fluid from women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

The expression of soluble intercellular adhesion molecule-1 in endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900216-3

7 January 2021

10.1016/S1567-5769(02)00216-3

Identifiers

DOI

1 reference

22 September 2017

1 reference